Ana L. Ricobaraza

Av. Pio XII 55
Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.

Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: May 05, 2023

Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.

Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.

Journal: International journal of molecular sciences

Published: November 04, 2022

Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome.

Viral vector-mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome.

Journal: The Journal of clinical investigation

Published: February 14, 2022

Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis.

Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis.

Journal: Molecular therapy. Methods & clinical development

Published: May 07, 2021

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations.

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations.

Journal: Molecular therapy. Nucleic acids

Published: May 04, 2021

Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.

Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.

Journal: Scientific reports

Published: April 14, 2021

Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence.

Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence.

Journal: International journal of molecular sciences

Published: January 30, 2021

Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis.

Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis.

Journal: International journal of molecular sciences

Published: January 13, 2021

Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome.

Alterations of the Hippocampal Neurogenic Niche in a Mouse Model of Dravet Syndrome.

Journal: Frontiers in cell and developmental biology

Published: May 04, 2020

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.

Journal: International journal of molecular sciences

Published: April 22, 2020

Danio Rerio as Model Organism for Adenoviral Vector Evaluation.

Danio Rerio as Model Organism for Adenoviral Vector Evaluation.

Journal: Genes

Published: November 14, 2019

Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.

Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation.

Journal: Scientific reports

Published: May 08, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026